Product details

By continuing to use our site you consent to the use of cookies as described in our privacy policy unless you have disabled them.
You can change your cookie settings at any time but parts of our site will not function correctly without them.
Case
-
Reference no. 9-811-089
Subject category: Entrepreneurship
Published by: Harvard Business Publishing
Originally published in: 2011
Version: 25 October 2013
Revision date: 18-Jun-2014
Length: 26 pages
Data source: Generalised experience

Abstract

In March 2010, US District Court Judge Robert Sweet overturned 30 years of legal precedent and ruled that unaltered human genes could not be patented. This case reviews patent law and how it relates to our increasing knowledge of the Human Genome. The case issues deal with the potential implications of Judge Sweet's decision for biotechnology entrepreneurs and investors.
Location:
Other setting(s):
2010

About

Abstract

In March 2010, US District Court Judge Robert Sweet overturned 30 years of legal precedent and ruled that unaltered human genes could not be patented. This case reviews patent law and how it relates to our increasing knowledge of the Human Genome. The case issues deal with the potential implications of Judge Sweet's decision for biotechnology entrepreneurs and investors.

Settings

Location:
Other setting(s):
2010

Related